Total Customers Served: 71,770 – Sales Per Customer: JPY 6,505 – Customer Repeat Ratio: 80.8%
September 2022_Number of Salons
September 2022_Operation Ratio
September 2022_Repeat Ratio
September 2022_Sales per Customer
September 2022_Total Customers Served
NEW YORK, Oct. 20, 2022 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of September 2022. Data is provided for all salons for which comparative financial and customer data is available and excludes certain salons where such information is not available.
The following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of September 2022.
Number of Salons (*1) | Number of Salons with Data (*2) | Total Customers Served (*3) | Sales per Customer (*4) | Repeat Ratio (*5) | Operation Ratio (*6) | |||
September-21 | 316 | 221 | 65,130 | JPY 6,428 | 82.0 | % | 46.7 | % |
October-21 | 316 | 221 | 68,608 | JPY 6,486 | 83.3 | % | 48.9 | % |
November-21 | 316 | 221 | 65,569 | JPY 6,466 | 81.9 | % | 47.7 | % |
December-21 | 312 | 221 | 71,173 | JPY 6,634 | 81.7 | % | 50.5 | % |
January-22 | 312 | 221 | 62,747 | JPY 6,570 | 82.4 | % | 48.2 | % |
February-22 | 310 | 219 | 54,443 | JPY 6,662 | 83.8 | % | 46.4 | % |
March-22 | 310 | 217 | 61,417 | JPY 6,595 | 82.4 | % | 46.5 | % |
April-22 | 309 | 232 | 69,986 | JPY 6,616 | 82.0 | % | 48.3 | % |
May-22 | 308 | 232 | 77,291 | JPY 6,461 | 79.6 | % | 50.1 | % |
June-22 | 307 | 231 | 73,259 | JPY 6,511 | 80.4 | % | 50.3 | % |
July-22 | 309 | 231 | 76,521 | JPY 6,668 | 80.6 | % | 50.3 | % |
August-22 | 311 | 232 | 72,250 | JPY 6,705 | 80.1 | % | 49.8 | % |
September-22 | 312 | 233 | 71,770 | JPY 6,505 | 80.8 | % | 50.3 | % |
(*1) Number of Salons: Includes our directly-operated salons and franchisees’ salons.
(*2) Number of Salons with Data: The number of salons for which comparable financial and customer data is available.
(*3) Total Customers Served: The number of customers served at salons for which comparative financial and customer data is available.
(*4) Sales Per Customer: The ratio of total salon sales to number of treated customers at all salons for which comparable financial and customer data is available.
(*5) Repeat Ratio: The ratio of repeat customer visits to total customer visits in the applicable month for all salons for which comparable financial and customer data is available.
(*6) Operation Ratio: The ratio of therapists’ in-service time to total therapists’ working hours (including stand-by time) for the applicable month for all salons for which comparable financial and customer data is available.
*Since July 2021, the salon operation business has been managed by Wing Inc., which is a wholly-owned subsidiary of the Company.
About MEDIROM Healthcare Technologies Inc.
MEDIROM, a holistic healthcare company, operates 312 (as of September 30, 2022) relaxation salons across Japan, Re.Ra.Ku®, being its leading brand, and provides healthcare services. In 2015, MEDIROM entered the health tech business, and launched new healthcare programs using on-demand training app called “Lav®”, which is developed by the Company. MEDIROM also entered the device business in 2020 and has developed a smart tracker “MOTHER Bracelet®”. MEDIROM hopes that its diverse health related services and products offering will help it collect and manage healthcare data from users and customers and enable it to become a leader in big data in the healthcare industry. For more information, visit https://medirom.co.jp/en
Forward-Looking Statements
Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about the Company’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,” “project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to the Company’s future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause the Company’s actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond the Company’s control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth strategy and liquidity. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Photo accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d988500b-abd6-4b70-9ff2-f5aa5f462f6a
https://www.globenewswire.com/NewsRoom/AttachmentNg/d2beb7ce-54ec-4126-a2f6-85243b27072d
https://www.globenewswire.com/NewsRoom/AttachmentNg/79c109bf-3fef-4702-9a23-a9cc708b106d
https://www.globenewswire.com/NewsRoom/AttachmentNg/55c005fa-80ab-4a0f-848e-3df3b82d300c
https://www.globenewswire.com/NewsRoom/AttachmentNg/5ef22495-9c94-4f97-b0b8-a25e33d4af1a
CONTACT: Contacts Investor Relations Team ir@medirom.co.jp
- Attruby is the first and only approved product with aspecifying near-complete stabilization…
PALO ALTO, Calif., Nov. 22, 2024 /PRNewswire/ -- Aulisa® Medical USA, Inc., a leader in…
NEW YORK, Nov. 22, 2024 /PRNewswire/ -- Report on how AI is redefining market landscape -…
Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…
3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…
The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…